CML results from t(9;22) that leads to the generation of hybrid fusion gene BCR-ABL1 which generates genomic instability by disrupting the balance between proliferation and apoptosis of cells and drives the leukemic changes in CML (2, 3). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.